 | • レポートコード：QY20ST-08057 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のTDS（経皮デリバリーシステム）市場について種類別（単層粘着剤、多層粘着剤、その他）、用途別（ Hospital Clinic Other ）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・TDS（経皮デリバリーシステム）市場の概要 ・世界の主要地域別TDS（経皮デリバリーシステム）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のTDS（経皮デリバリーシステム）市場規模2015-2026：種類別（単層粘着剤、多層粘着剤、その他） ・世界のTDS（経皮デリバリーシステム）市場規模2015-2026：用途別（ Hospital Clinic Other ） ・TDS（経皮デリバリーシステム）の北米市場規模2015-2020 ・TDS（経皮デリバリーシステム）のヨーロッパ市場規模2015-2020 ・TDS（経皮デリバリーシステム）の中国市場規模2015-2020 ・TDS（経皮デリバリーシステム）の日本市場規模2015-2020 ・TDS（経皮デリバリーシステム）の東南アジア市場規模2015-2020 ・TDS（経皮デリバリーシステム）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・TDS（経皮デリバリーシステム）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・TDS（経皮デリバリーシステム）の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global TDS(Transdermal Delivery Systems) Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the TDS(Transdermal Delivery Systems) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the TDS(Transdermal Delivery Systems) industry.
Based on our recent survey, we have several different scenarios about the TDS(Transdermal Delivery Systems) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of TDS(Transdermal Delivery Systems) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global TDS(Transdermal Delivery Systems) Scope and Market Size
The global TDS(Transdermal Delivery Systems) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global TDS(Transdermal Delivery Systems) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the TDS(Transdermal Delivery Systems) market is segmented into
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Others
Segment by Application, the TDS(Transdermal Delivery Systems) market is segmented into
Hospital
Clinic
Other
The TDS(Transdermal Delivery Systems) market is analysed and market size information is provided by regions (countries). Segment by Application, the TDS(Transdermal Delivery Systems) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and TDS(Transdermal Delivery Systems) Market Share Analysis
TDS(Transdermal Delivery Systems) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in TDS(Transdermal Delivery Systems) business, the date to enter into the TDS(Transdermal Delivery Systems) market, TDS(Transdermal Delivery Systems) product introduction, recent developments, etc.
The major vendors covered:
Adhex Pharma
Harro Hofliger
Tesa Labtec
Toyochem
Teva Pharmaceutical
Pfizer
IBSA Group
Teikoku Seiyaku
Endo International
Hisamitsu
Mylan
Sorrento Therapeutics
1 TDS(Transdermal Delivery Systems) Market Overview
1.1 TDS(Transdermal Delivery Systems) Product Scope
1.2 TDS(Transdermal Delivery Systems) Segment by Type
1.2.1 Global TDS(Transdermal Delivery Systems) Sales by Type (2020-2026)
1.2.2 Single-layer Drug-in-Adhesive
1.2.3 Multi-layer Drug-in-Adhesive
1.2.4 Others
1.3 TDS(Transdermal Delivery Systems) Segment by Application
1.3.1 Global TDS(Transdermal Delivery Systems) Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 TDS(Transdermal Delivery Systems) Market Estimates and Forecasts (2015-2026)
1.4.1 Global TDS(Transdermal Delivery Systems) Sales Growth Rate (2015-2026)
1.4.2 Global TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2015-2026)
1.4.3 Global TDS(Transdermal Delivery Systems) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): TDS(Transdermal Delivery Systems) Industry Impact
1.5.1 How the Covid-19 is Affecting the TDS(Transdermal Delivery Systems) Industry
1.5.1.1 TDS(Transdermal Delivery Systems) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and TDS(Transdermal Delivery Systems) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for TDS(Transdermal Delivery Systems) Players to Combat Covid-19 Impact
2 TDS(Transdermal Delivery Systems) Estimate and Forecast by Region
2.1 Global TDS(Transdermal Delivery Systems) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global TDS(Transdermal Delivery Systems) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Region (2015-2020)
2.2.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region (2015-2020)
2.3 Global TDS(Transdermal Delivery Systems) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global TDS(Transdermal Delivery Systems) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States TDS(Transdermal Delivery Systems) Estimates and Projections (2015-2026)
2.4.2 Europe TDS(Transdermal Delivery Systems) Estimates and Projections (2015-2026)
2.4.3 China TDS(Transdermal Delivery Systems) Estimates and Projections (2015-2026)
2.4.4 Japan TDS(Transdermal Delivery Systems) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia TDS(Transdermal Delivery Systems) Estimates and Projections (2015-2026)
2.4.6 India TDS(Transdermal Delivery Systems) Estimates and Projections (2015-2026)
3 Global TDS(Transdermal Delivery Systems) Competition Landscape by Players
3.1 Global Top TDS(Transdermal Delivery Systems) Players by Sales (2015-2020)
3.2 Global Top TDS(Transdermal Delivery Systems) Players by Revenue (2015-2020)
3.3 Global TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TDS(Transdermal Delivery Systems) as of 2019)
3.4 Global TDS(Transdermal Delivery Systems) Average Price by Company (2015-2020)
3.5 Manufacturers TDS(Transdermal Delivery Systems) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key TDS(Transdermal Delivery Systems) Players (Opinion Leaders)
4 Global TDS(Transdermal Delivery Systems) Market Size by Type
4.1 Global TDS(Transdermal Delivery Systems) Historic Market Review by Type (2015-2020)
4.1.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
4.1.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Type (2015-2020)
4.1.3 Global TDS(Transdermal Delivery Systems) Price by Type (2014-2020)
4.2 Global TDS(Transdermal Delivery Systems) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Type (2021-2026)
4.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Type (2021-2026)
4.2.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Type (2021-2026)
5 Global TDS(Transdermal Delivery Systems) Market Size by Application
5.1 Global TDS(Transdermal Delivery Systems) Historic Market Review by Application (2015-2020)
5.1.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
5.1.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Application (2015-2020)
5.1.3 Global TDS(Transdermal Delivery Systems) Price by Application (2015-2020)
5.2 Global TDS(Transdermal Delivery Systems) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Application (2021-2026)
5.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Application (2021-2026)
5.2.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Application (2021-2026)
3 North America TDS(Transdermal Delivery Systems) Market Facts & Figures
3.2 North America TDS(Transdermal Delivery Systems) Sales Market Share by Company (2015-2020)
3.3 North America TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
3.4 North America TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
4 Europe TDS(Transdermal Delivery Systems) Market Facts & Figures
4.2 Europe TDS(Transdermal Delivery Systems) Sales Market Share by Company (2015-2020)
4.3 Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
4.4 Europe TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
5 China TDS(Transdermal Delivery Systems) Market Facts & Figures
5.2 China TDS(Transdermal Delivery Systems) Sales Market Share by Company (2015-2020)
5.3 China TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
5.4 China TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
6 Japan TDS(Transdermal Delivery Systems) Market Facts & Figures
6.2 Japan TDS(Transdermal Delivery Systems) Sales Market Share by Company (2015-2020)
6.3 Japan TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
6.4 Japan TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
7 Southeast Asia TDS(Transdermal Delivery Systems) Market Facts & Figures
7.2 Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
8 India TDS(Transdermal Delivery Systems) Market Facts & Figures
8.2 India TDS(Transdermal Delivery Systems) Sales Market Share by Company (2015-2020)
8.3 India TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
8.4 India TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in TDS(Transdermal Delivery Systems) Business
12.1 Adhex Pharma
12.1.1 Adhex Pharma TDS(Transdermal Delivery Systems) Corporation Information
12.1.2 Adhex Pharma TDS(Transdermal Delivery Systems) Business Overview and Total Revenue
12.1.3 Adhex Pharma TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Adhex Pharma TDS(Transdermal Delivery Systems) Products Offered
12.1.5 Adhex Pharma Recent Development
12.2 Harro Hofliger
12.2.1 Harro Hofliger TDS(Transdermal Delivery Systems) Corporation Information
12.2.2 Harro Hofliger TDS(Transdermal Delivery Systems) Business Overview and Total Revenue
12.2.3 Harro Hofliger TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Harro Hofliger TDS(Transdermal Delivery Systems) Products Offered
12.2.5 Harro Hofliger Recent Development
12.3 Tesa Labtec
12.3.1 Tesa Labtec TDS(Transdermal Delivery Systems) Corporation Information
12.3.2 Tesa Labtec TDS(Transdermal Delivery Systems) Business Overview and Total Revenue
12.3.3 Tesa Labtec TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Tesa Labtec TDS(Transdermal Delivery Systems) Products Offered
12.3.5 Tesa Labtec Recent Development
12.4 Toyochem
12.4.1 Toyochem TDS(Transdermal Delivery Systems) Corporation Information
12.4.2 Toyochem TDS(Transdermal Delivery Systems) Business Overview and Total Revenue
12.4.3 Toyochem TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Toyochem TDS(Transdermal Delivery Systems) Products Offered
12.4.5 Toyochem Recent Development
12.5 Teva Pharmaceutical
12.5.1 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Corporation Information
12.5.2 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Business Overview and Total Revenue
12.5.3 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Products Offered
12.5.5 Teva Pharmaceutical Recent Development
12.6 Pfizer
12.6.1 Pfizer TDS(Transdermal Delivery Systems) Corporation Information
12.6.2 Pfizer TDS(Transdermal Delivery Systems) Business Overview and Total Revenue
12.6.3 Pfizer TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pfizer TDS(Transdermal Delivery Systems) Products Offered
12.6.5 Pfizer Recent Development
12.7 IBSA Group
12.7.1 IBSA Group TDS(Transdermal Delivery Systems) Corporation Information
12.7.2 IBSA Group TDS(Transdermal Delivery Systems) Business Overview and Total Revenue
12.7.3 IBSA Group TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 IBSA Group TDS(Transdermal Delivery Systems) Products Offered
12.7.5 IBSA Group Recent Development
12.8 Teikoku Seiyaku
12.8.1 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Corporation Information
12.8.2 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Business Overview and Total Revenue
12.8.3 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Products Offered
12.8.5 Teikoku Seiyaku Recent Development
12.9 Endo International
12.9.1 Endo International TDS(Transdermal Delivery Systems) Corporation Information
12.9.2 Endo International TDS(Transdermal Delivery Systems) Business Overview and Total Revenue
12.9.3 Endo International TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Endo International TDS(Transdermal Delivery Systems) Products Offered
12.9.5 Endo International Recent Development
12.10 Hisamitsu
12.10.1 Hisamitsu TDS(Transdermal Delivery Systems) Corporation Information
12.10.2 Hisamitsu TDS(Transdermal Delivery Systems) Business Overview and Total Revenue
12.10.3 Hisamitsu TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Hisamitsu TDS(Transdermal Delivery Systems) Products Offered
12.10.5 Hisamitsu Recent Development
12.11 Mylan
12.11.1 Mylan TDS(Transdermal Delivery Systems) Corporation Information
12.11.2 Mylan TDS(Transdermal Delivery Systems) Business Overview and Total Revenue
12.11.3 Mylan TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Mylan TDS(Transdermal Delivery Systems) Products Offered
12.11.5 Mylan Recent Development
12.12 Sorrento Therapeutics
12.12.1 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Corporation Information
12.12.2 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Business Overview and Total Revenue
12.12.3 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Products Offered
12.12.5 Sorrento Therapeutics Recent Development
13 TDS(Transdermal Delivery Systems) Manufacturing Cost Analysis
13.1 TDS(Transdermal Delivery Systems) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of TDS(Transdermal Delivery Systems)
13.4 TDS(Transdermal Delivery Systems) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 TDS(Transdermal Delivery Systems) Distributors List
14.3 TDS(Transdermal Delivery Systems) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global TDS(Transdermal Delivery Systems) Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global TDS(Transdermal Delivery Systems) Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four TDS(Transdermal Delivery Systems) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for TDS(Transdermal Delivery Systems) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for TDS(Transdermal Delivery Systems) Players to Combat Covid-19 Impact
Table 8. Global Market TDS(Transdermal Delivery Systems) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global TDS(Transdermal Delivery Systems) Sales (K Units) by Region (2015-2020)
Table 10. Global TDS(Transdermal Delivery Systems) Sales Market Share by Region (2015-2020)
Table 11. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global TDS(Transdermal Delivery Systems) Revenue Share by Region (2015-2020)
Table 13. Global TDS(Transdermal Delivery Systems) Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global TDS(Transdermal Delivery Systems) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global TDS(Transdermal Delivery Systems) Revenue Share Forecast by Region (2021-2026)
Table 17. Global TDS(Transdermal Delivery Systems) (K Units) of Key Companies (2015-2020)
Table 18. Global TDS(Transdermal Delivery Systems) Sales Share by Company (2015-2020)
Table 19. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global TDS(Transdermal Delivery Systems) Revenue Share by Company (2015-2020)
Table 21. Global TDS(Transdermal Delivery Systems) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TDS(Transdermal Delivery Systems) as of 2019)
Table 22. Global TDS(Transdermal Delivery Systems) Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers TDS(Transdermal Delivery Systems) Manufacturing Sites and Area Served
Table 24. Manufacturers TDS(Transdermal Delivery Systems) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key TDS(Transdermal Delivery Systems) Players
Table 27. Global TDS(Transdermal Delivery Systems) Sales (K Units) by Type (2015-2020)
Table 28. Global TDS(Transdermal Delivery Systems) Sales Share by Type (2015-2020)
Table 29. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global TDS(Transdermal Delivery Systems) Price (K Units) by Type (2015-2020)
Table 31. Global TDS(Transdermal Delivery Systems) Sales Share by Type (2021-2026)
Table 32. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global TDS(Transdermal Delivery Systems) Revenue Share by Type (2021-2026)
Table 34. Global TDS(Transdermal Delivery Systems) Price (K Units) by Type (2021-2026)
Table 35. Global TDS(Transdermal Delivery Systems) Sales (K Units) by Application (2015-2020)
Table 36. Global TDS(Transdermal Delivery Systems) Sales Share by Application (2015-2020)
Table 37. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global TDS(Transdermal Delivery Systems) Price (K Units) by Application (2015-2020)
Table 39. Global TDS(Transdermal Delivery Systems) Sales (K Units) by Application (2021-2026)
Table 40. Global TDS(Transdermal Delivery Systems) Sales Share by Application (2021-2026)
Table 41. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global TDS(Transdermal Delivery Systems) Revenue Share by Application (2021-2026)
Table 43. Global TDS(Transdermal Delivery Systems) Price (K Units) by Application (2021-2026)
Table 44. United States TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2015-2020)
Table 45. United States TDS(Transdermal Delivery Systems) Sales Market Share by Company (2015-2020)
Table 46. United States TDS(Transdermal Delivery Systems) Sales (K Units) by Type (2015-2020)
Table 47. United States TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 48. United States TDS(Transdermal Delivery Systems) Sales (K Units) by Application (2015-2020)
Table 49. United States TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 50. Europe TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2015-2020)
Table 51. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Company (2015-2020)
Table 52. Europe TDS(Transdermal Delivery Systems) Sales (K Units) by Type (2015-2020)
Table 53. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 54. Europe TDS(Transdermal Delivery Systems) Sales (K Units) by Application (2015-2020)
Table 55. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 56. China TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2015-2020)
Table 57. China TDS(Transdermal Delivery Systems) Sales Market Share by Company (2015-2020)
Table 58. China TDS(Transdermal Delivery Systems) Sales (K Units) by Type (2015-2020)
Table 59. China TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 60. China TDS(Transdermal Delivery Systems) Sales (K Units) by Application (2015-2020)
Table 61. China TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 62. Japan TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2015-2020)
Table 63. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Company (2015-2020)
Table 64. Japan TDS(Transdermal Delivery Systems) Sales (K Units) by Type (2015-2020)
Table 65. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 66. Japan TDS(Transdermal Delivery Systems) Sales (K Units) by Application (2015-2020)
Table 67. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia TDS(Transdermal Delivery Systems) Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia TDS(Transdermal Delivery Systems) Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 74. India TDS(Transdermal Delivery Systems) Sales (K Units) by Company (2015-2020)
Table 75. India TDS(Transdermal Delivery Systems) Sales Market Share by Company (2015-2020)
Table 76. India TDS(Transdermal Delivery Systems) Sales (K Units) by Type (2015-2020)
Table 77. India TDS(Transdermal Delivery Systems) Sales Market Share by Type (2015-2020)
Table 78. India TDS(Transdermal Delivery Systems) Sales (K Units) by Application (2015-2020)
Table 79. India TDS(Transdermal Delivery Systems) Sales Market Share by Application (2015-2020)
Table 80. Adhex Pharma Corporation Information
Table 81. Adhex Pharma Description and Business Overview
Table 82. Adhex Pharma TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Adhex Pharma TDS(Transdermal Delivery Systems) Product
Table 84. Adhex Pharma Recent Development
Table 85. Harro Hofliger Corporation Information
Table 86. Harro Hofliger Description and Business Overview
Table 87. Harro Hofliger TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Harro Hofliger TDS(Transdermal Delivery Systems) Product
Table 89. Harro Hofliger Recent Development
Table 90. Tesa Labtec Corporation Information
Table 91. Tesa Labtec Description and Business Overview
Table 92. Tesa Labtec TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Tesa Labtec TDS(Transdermal Delivery Systems) Product
Table 94. Tesa Labtec Recent Development
Table 95. Toyochem Corporation Information
Table 96. Toyochem Description and Business Overview
Table 97. Toyochem TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Toyochem TDS(Transdermal Delivery Systems) Product
Table 99. Toyochem Recent Development
Table 100. Teva Pharmaceutical Corporation Information
Table 101. Teva Pharmaceutical Description and Business Overview
Table 102. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Product
Table 104. Teva Pharmaceutical Recent Development
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Pfizer TDS(Transdermal Delivery Systems) Product
Table 109. Pfizer Recent Development
Table 110. IBSA Group Corporation Information
Table 111. IBSA Group Description and Business Overview
Table 112. IBSA Group TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. IBSA Group TDS(Transdermal Delivery Systems) Product
Table 114. IBSA Group Recent Development
Table 115. Teikoku Seiyaku Corporation Information
Table 116. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Teikoku Seiyaku Description and Business Overview
Table 118. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Product
Table 119. Teikoku Seiyaku Recent Development
Table 120. Endo International Corporation Information
Table 121. Endo International TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Endo International Description and Business Overview
Table 123. Endo International TDS(Transdermal Delivery Systems) Product
Table 124. Endo International Recent Development
Table 125. Hisamitsu Corporation Information
Table 126. Hisamitsu Description and Business Overview
Table 127. Hisamitsu TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Hisamitsu TDS(Transdermal Delivery Systems) Product
Table 129. Hisamitsu Recent Development
Table 130. Mylan Corporation Information
Table 131. Mylan Description and Business Overview
Table 132. Mylan TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Mylan TDS(Transdermal Delivery Systems) Product
Table 134. Mylan Recent Development
Table . Sorrento Therapeutics Corporation Information
Table . Sorrento Therapeutics Description and Business Overview
Table . Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Sorrento Therapeutics TDS(Transdermal Delivery Systems) Product
Table . Sorrento Therapeutics Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. TDS(Transdermal Delivery Systems) Distributors List
Table 143. TDS(Transdermal Delivery Systems) Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. TDS(Transdermal Delivery Systems) Product Picture
Figure 2. Global TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global TDS(Transdermal Delivery Systems) Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Other Examples
Figure 9. Global TDS(Transdermal Delivery Systems) Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global TDS(Transdermal Delivery Systems) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global TDS(Transdermal Delivery Systems) Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States TDS(Transdermal Delivery Systems) Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe TDS(Transdermal Delivery Systems) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China TDS(Transdermal Delivery Systems) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan TDS(Transdermal Delivery Systems) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia TDS(Transdermal Delivery Systems) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India TDS(Transdermal Delivery Systems) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India TDS(Transdermal Delivery Systems) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest TDS(Transdermal Delivery Systems) Players Market Share by Revenue in TDS(Transdermal Delivery Systems) 2015 & 2019
Figure 27. TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global TDS(Transdermal Delivery Systems) Revenue Share by Type (2015-2020)
Figure 29. Global TDS(Transdermal Delivery Systems) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global TDS(Transdermal Delivery Systems) Revenue Share by Application (2015-2020)
Figure 31. Global TDS(Transdermal Delivery Systems) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2019
Figure 33. United States TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2019
Figure 34. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Company in 2019
Figure 35. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2019
Figure 36. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2019
Figure 37. China TDS(Transdermal Delivery Systems) Sales Market Share by Company in 2019
Figure 38. China TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2019
Figure 39. China TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2019
Figure 40. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Company in 2019
Figure 41. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2019
Figure 42. Japan TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2019
Figure 43. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Company in 2019
Figure 44. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2019
Figure 45. Southeast Asia TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2019
Figure 46. India TDS(Transdermal Delivery Systems) Sales Market Share by Company in 2019
Figure 47. India TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2019
Figure 48. India TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2019
Figure 49. Adhex Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Harro Hofliger Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Tesa Labtec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Toyochem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. IBSA Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Teikoku Seiyaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Hisamitsu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Sorrento Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of TDS(Transdermal Delivery Systems)
Figure 63. Manufacturing Process Analysis of TDS(Transdermal Delivery Systems)
Figure 64. TDS(Transdermal Delivery Systems) Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
経皮/経粘膜ドラッグデリバリーシステムの世界市場レポート2020 A recently published report by QY Research titled Global Transdermal/Transmucosal Drug Delivery System Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also stat…- 経皮治療システム（TTS）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Transdermal Therapeutic Systems (TTS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- IOLデリバリーシステムの世界市場レポート2020 The IOL delivery system is a safer, simpler, more efficient and advanced delivery system for the intraocular lens (IOL) delivery system. The IOL delivery system benefits cataract surgery by simplifying surgical procedures in a shorter time. Market Analysis and Insights: Global IOL Delivery Systems M…
- 経粘膜ドラッグデリバリ装置の世界市場レポート2020 A recently published report by QY Research titled Global Transmucosal Drug Delivery Devices Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically p…
- リドカイン経皮パッチの世界市場レポート2020 Lidocaine is chemically known as acetamide, 2- (diethylamino) -n - (2, 6-dimethyl phenyl), octanol at pH 7.4;Moisture ratio for 43, lidocaine transdermal patch is suitable for adults and adolescents 12 years of age or temporary pain relief including 5% lidocaine transdermal patches, 1.8% lidocaine t…